Executive Director owns 0.036% per cent of company’s issued share capital.
In a financial bulletin, Benchmark reports that Executive Director and Chief Scientific Officer Alex Raeber has purchased 200,000 ordinary shares of 0.1 pence each in Benchmark at a price of 43.5 pence per share on Thursday.
Following this transaction, Raeber’s total beneficial interest in the Company is 200,000 Ordinary Shares – representing approximately 0.036% per cent of Benchmark’s issued share capital.
